We are an international
independent scientific network

devoted to advancing research on optimising the prevention,
diagnosis and treatment of infectious diseases in children globally

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

Sharing values and goals

such as flexibility, commitment and transparency

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

Understanding the
immune response

so as to harness the body's response
to HIV and antiretrovirals

Fighting
antimicrobial resistance

to ensure effective treatments are available
for common infections for generations to come

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

Get to know us

Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Current Penta studies around the World

Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Latest News

Penta joins CoMeCT, a new European project to boost clinical research preparedness for future infectious disease outbreaks

22 Feb, 2024

CoMeCT, short for Coordination Mechanism for Cohorts and Trials, is a new EU-funded project aiming to strengthen European preparedness and response capacity for future health emergencies. Over the next three…
Read More

Penta teams up with IAVI and Achilles Vaccines to develop new treatments for HIV, emerging infections and neglected diseases

01 Feb, 2024

Penta – Child Health Research announced a new collaboration with IAVI and Achilles Vaccines to accelerate the development of treatments for HIV, emerging infections and neglected diseases affecting children. This…
Read More

Advancing Paediatric Antibiotic Research: Two New African-European Research Collaborations Tackle Severe Infections in Neonates and Children

30 Jan, 2024

This week, expert scientists and clinicians from PediCAP and SNIP-AFRICA, two major research partnerships combatting antimicrobial resistance, convene in Johannesburg to present groundbreaking results and ways to advance antibiotic research…
Read More

Empowering young voices through Penta’s Youth Trial Boards (YTB)

22 Jan, 2024

For the past 6 years, Penta has run an initiative called the Youth Trial Boards (YTB), a platform for adolescents who are living with specific health conditions to actively participate…
Read More

Rewatch the NeoIPC CPN webinar: “The role of surveillance in preventing hospital-acquired infections among newborns”

02 Jan, 2024

The NeoIPC Clinical Practice Network successfully hosted a webinar on 23 November 2023, addressing the critical topic of surveillance of hospital-acquired infections in newborns. With 130 participants attending the online…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people